Paradigm Asset Management’s ANACOR PHARMACEUTICALS INC COM ANAC Stock Holding History

Paradigm Asset Management’s Portfolio ANAC Stock Details ANAC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-10,400	Closed	-$556K	–	872
2016 Q1	$556K	Hold	10,400	–	–	0.1%	207
2015 Q4	$1.17M	Buy	10,400 +9,350	+890%	+$1.03M	0.2%	106
2015 Q3	$124K	Buy	+1,050	New	+$137K	0.02%	498

Other funds holding ANAC

KCM

Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return

CIM

CIM Investment Management Pittsburgh, Pennsylvania $375M AUM 32.03% 1-Year Est. Return

Paradigm Asset Management's ANAC Position: Q2 2016 in Review

Paradigm Asset Management sold out of ANACOR PHARMACEUTICALS INC COM (ANAC) in Q2 2016, closing a stake of 10,400 shares — an estimated $556K sold.

Paradigm Asset Management first reported a position in ANAC in Q3 2015 and held it in 3 quarters. The position peaked at $1.17M in Q4 2015. 2 funds tracked by Wall St. Rank hold ANAC as of Q2 2016.

Paradigm Asset Management reported no remaining ANACOR PHARMACEUTICALS INC COM position as of Q2 2016 after selling out during the quarter.
Paradigm Asset Management sold 10,400 ANACOR PHARMACEUTICALS INC COM shares in Q2 2016, an estimated $556K.
Paradigm Asset Management first reported a position in ANACOR PHARMACEUTICALS INC COM in Q3 2015 and held it in 3 quarters.
Paradigm Asset Management's ANACOR PHARMACEUTICALS INC COM position peaked at $1.17M in Q4 2015.
2 funds tracked by Wall St. Rank held ANACOR PHARMACEUTICALS INC COM as of Q2 2016.

Based on Paradigm Asset Management's 13F filing for Q2 2016, filed 12 Aug 2016.